KIF11 and neoplasm: This is also in accordance with our recent work in combining PT with antitumoral EG5 siRNA.9 Encouragingly, this favorable PT effect could be further enhanced by the co‐administration of the rather low dose of 5 mg kg−1 MTX, resulting in a significantly retarded tumor growth in the combination group.